Nexentis Soars 156% on AI Drug Discovery Plans, Shares Fall After the Bell
Nexentis Technologies shares soared 155.91% to $13.00 on massive volume after announcing an AI drug-discovery partnership and a $2.9 million stock-and-warrant financing at $7.056 per share, but fell 26.15% after hours as investors weighed the promise of new research against dilution risk and a going-concern warning.